期刊文献+

儿童早发型腓骨肌萎缩症2型21例线粒体融合蛋白2基因型和表型分析 被引量:2

Analysis of mitofusin 2 genotype and phenotype in 21 children with charact-marry-tooth type Ⅱ
下载PDF
导出
摘要 目的分析儿童腓骨肌萎缩症2型(CMT2)线粒体融合蛋白2(MFN2)基因型与临床表型。方法纳入1998至2012年首都医科大学附属北京儿童医院临床诊断的CMT2患儿为研究对象,采用直接测序方法检测MFN2突变基因,并描述分析突变和未突变患儿的临床表型、神经电生理、实验室和病理学检查特征。结果 21例CMT2患儿进入分析。①未检出MFN2基因突变18例(男14例,女4例),起病年龄平均3.3岁。其中9例累及下肢近端和远端,7例累及四肢,2例无法行走,8例下肢近端和远端肌肉萎缩,4例可见轻微感觉障碍。MFN2基因突变3例(男2例,女1例),起病年龄1.5~8岁,1例有家族史。均可见下肢近端和远端肌肉萎缩,2例足下垂并内翻,均有感觉障碍表现。②21例运动和(或)感觉神经传导速度≥38m·s-1或波幅降低,MFN2基因突变患儿腓总神经和胫神经复合肌肉动作电位波幅较正常值的下降幅度高于未突变患儿;③10例行腓肠神经活检检查,其中MFN2基因突变1例,未检出MFN2突变9例,均符合慢性轴索神经病病理改变,电镜下可见轴索线粒体聚集排列和肿胀。结论 MFN2基因突变是CMT2的致病原因之一,携带该突变患儿多为早发型,临床表型可能重于未突变者,仍需扩大样本量进一步分析。 Objective To analyze MFN2 mutations and associated phenotypes in patients with charact-marry-tooth (CMT) type Ⅱ. Methods Children diagnosed as CMT 2 in Beijing Childreng Hospital from 1998 to 2012 were included. Direct sequencing of the MFN2 gene and clinical investigations were performed in patients with MFN2 mutations. The clinical features, electrophysiological finding, labortory test and pathology of paitients with and without MFN2 mutations were analyzed. Results Twenty one cases with CMT 2 were included in the study. ①No gene mutation was detected in 18 cases (male 14 cases, female 4 cases). The average age of the onset of the disease was 3.3 years. Nine of them involved in both proximal end and distal end of lower limb, seven cases involved in limbs, two cases could not walk, eight cases were with myophagism of proximal and distal ends of lower limb, mild sensory disturbance could be detected in four cases. Three different missense mutations were identified in 3 patients ( male 2 cases, female 1 case). The age of onset ranged from 1.5 to 8 years, one had a family history of autosomal dominant inheritance. Myophagism of proximal and distal ends of lower limb could be found in all cases, foot drop with strephenopodia were observed in two cases, and all with sensory disturbance. ②Conduction velocity great than 38 m · s^-1 of motor nerve and/or sensory nerve, or decreased amplitude could be detected in all cases. The decreased value of CAMP of common peroneal nerve and tibial nerve was higher in MFN2 gene mutation children than that in children without MFN2 mutation. ③Sural nerve examination was performed in ten cases, one of them with MFN2 gene mutation, nine without MFN2 gene mutation, prominent mitochondrial abnormalities in both myelinated and unmyelinated nerve fibers were observed under electronic microscope. Conclusions MFN2 mutations was one of the causes of CMT2 with either dominant or recessive inheritance. The age of onset of patients with MFN2 gene mutation usually was before 10 years old.
出处 《中国循证儿科杂志》 CSCD 2013年第2期131-135,共5页 Chinese Journal of Evidence Based Pediatrics
基金 北京市教育委员会科技计划面上项目:KM200910025021
关键词 腓骨肌萎缩症2型 线粒体融合蛋白2基因 临床表型 儿童 Charact-marry-tooth type Ⅱ MFN2 gene Phenotype Children
  • 相关文献

参考文献14

  • 1Peter J. Dyck PKT. Peripheral neuropathy. 4rd eded. philadelphia: W. B. Sauders, 2005.
  • 2Ryan MM, Ouvrier R. Hereditary peripheral neuropathies of childhood. CUff Opin Neurol, 2005, 18( 2): 105-110.
  • 3吕俊兰,吴沪生,郎志奇,邹丽萍,方方,丁昌红,周文敏.腓骨肌萎缩症患儿周围神经电生理和组织病理学的研究[J].中华儿科杂志,2002,40(3):173-176. 被引量:5
  • 4吕俊兰.儿童遗传性周围神经病[J].实用儿科临床杂志,2006,21(12):723-725. 被引量:3
  • 5Calvo J, Funalot B, Ouvrier RA, et al. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Arch Neurol, 2009, 66( 12) : 1511-1516.
  • 6Ouvrier R, Grew S. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults. Dev Med Child Neurol, 2010,52(4):328-330.
  • 7Engelfried K, Vorgerd M, Hagedorn M, et al. Charcot-MarieTooth neuropathy type 2A: novel mutations in the mitofusin 2 gene ( MFN2). BMC Med Genet, 2006,7: 53.
  • 8Baloh RH, Schmidt RE, Pestronk A, et al. Altered axonal mitochondrial transport in the pathogenesis of Charcot-MarieTooth disease from mitofusin 2 mutations. J Neurosci, 2007,27 (2):422-430.
  • 9Verhoeven K, Claeys KG, Zuchner S, et al. MFN2 mutation distribution and genotype/phenotype correlation in charcotMarie-Tooth type 2. Brain, 2006, 129( Pt 8): 2093-2102.
  • 10Chung KW, Kim SB, Park KD, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain, 2006, 129( Pt 8): 2103-2118.

二级参考文献19

  • 1章远志,Nanbert ZHONG.腓骨肌萎缩症的分子遗传学研究[J].北京大学学报(医学版),2005,37(1):100-105. 被引量:2
  • 2张杰敏,蔡方成.0~14岁小儿感觉神经的传导功能[J].中华儿科杂志,1995,33(1):19-21. 被引量:12
  • 3Ouvrier BA,Mcleo J,Conchin TE.The hypertrophic forms of hereditary motor and sensory neuropathy.Brain,1987,110:121-148.
  • 4Fabrizi GM,Cavalb T,Taioli F.Myelin uncompaction in Charcot-Marie-Tooth neuropathy type ⅠA with a point muatation of peripheral myelin protein-22.Neurology,1999,53:846-851.
  • 5Senderek J,Bergmm C,Quasthoff S,et al.X-linked dominant Charcot-Marre-Tooth disease:nerve biopsies allow morphological evaluation and detection of connexin 32 mutations(Argl5Trp,Arg22Gin).Ann Neuropathol,1998,95:443-449.
  • 6Swaiman KF,Iannaccone ST.Hereditary Neuropathies.In:Swaiman KF,ed.Pediatric Neurology.3rd,St.Louis:Mosby,1999.1184-1189.
  • 7Dyck PJ.Inherited neuronal degeneration and arophy affecting affecting peripheral motor,sensory,and autonomiac neurons.In:Dyck PJ,eds.Peripheral Neuropathy,vol 2.2nd ed.Philadelphia and London:WB Saunders,1600-1655.
  • 8Cornblath DR.Electrophysiology in Guillain-Barre syndrome.Ann Neurol,1990(Suppl):17-20.
  • 9Harding AE.From the syndrome of Charcot,Marie and Tooth to disorders of peripheral myelin proteins.Brain,1995,118:809.
  • 10Harding AE,Thomas PK.The clinical features of hereditary motor and sensory neuropathy type Ⅰ and Ⅱ.Brain,1980,103:259.

共引文献6

同被引文献44

  • 1Rube DA,van der Bliek AM.Mitochondrial morphology is dynamic and varied.Mol Cell Biochem,2004,256:331-339.
  • 2Chan DC.Mitochondrial fusion and fission in mammals.Annu Rev Cell Dev Biol,2006,22:79-99.
  • 3JoséMG,Alexander TA,Gordon WM.Mitochondria in heart failure:the emerging role of mitochondrial dynamics.J Card Fail,2013,18(4):439-456.
  • 4曲东明.线粒体融合蛋白2与胰岛素抵抗的关系及其机制研究.河北医科大学博士学位论文,2008.
  • 5Sang-Bing O,Andrew RH,Derek J,et al.Mitochondrial dynamics in cardiovascular health and disease.Antioxid Redox Signal,2013,19(4):400-414.
  • 6JoséMG.Mitochondrial dynamics in health and disease.Mitochondria and their role in cardiovascular disease.Springer,2013:329-342.
  • 7Chen H,Chomyn A,Chan DC.Disruption of fusion results in mitochondrial heterogeneity and dysfunction.J Biol Chem,2005,280(28):26185-92.
  • 8陈景元.线粒体融合、分裂在细胞寒冷应激中作用及其机制的初步研究.第四军医大学博士学位论文,2008.
  • 9Pich S,Bach D,Briones P,et al.The Charcot–Marie–Tooth type 2A gene product,Mfn2,up-regulates fuel oxidation through expression of OXPHOS system.Hum Mol Genet,2005,14:1405-1415.
  • 10Bach D,Pich S,Soriano FX,et al.Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism,a novel regulatory mechanism altered in obesity.J Biol Chem,2003,278:17190-17197.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部